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ABSTRACT
The effect of four doses of dopamine (1o-9M, 10-7M,
10- 5M and 10- 3M) and dopamine-receptor agonistic and
antagonistic agents on renin release and 3' 5' -adenosine
monophosphate (c-AMP) content of renal cortical tissue
slices from sodium-deficient rats was studies in vitro.
Male, Sprague-Dawley rats weighing

210~10

g were fed a

sodium deficient diet (less than 0.02 mEg/day) for periods
of time of 2-3 weeks.

Following decapitation, renal

cortical slices weighing 50
a Stadie-Riggs microtome.

~

20 mg were prepared using

After a 15 minute preincubation

period, they were incubated for 1 hr at 37°C in Robinson's
buffer medium with continuous 95%

o2

- 5% C02 gassing,

in the presence or absence (control) of the pharmacological
agents.

Addition of 10- 5M and 10- 3M dopamine doses to

the kidney slice preparation significantly stimulated renin
release, and the c-AMP content of the renal cortical tissue
slices was also significantly greater than controls at
10- 3M dopamine concentration.

Dopamine doses lower than

10- 5M were ineffective in stimulating either renin release
or tissue c-AMP content.

Addition of the dopamine-receptor

blocking agent pimozide (10- 6 M) effectively inhibited the
stimulatory effect of two dopamine concentrations (10-5M

ix

-and 10- 3M) on renin secretion, while significantly
decreasing tissue c-AMP content levels below those of
control in slices treated with all four dopamine
concentrations.

Pimozide added alone to the tissue slice

system signficantly decreased both renin release and tissue
c-AMP content levels below those seen in control slices.
The dopamine-receptor agonist apomorphine (1o-6M) added
to the in vitro slice preparation did not potentiate but
actually prevented stimulation of renin release by dopamine
(10- 5M and 10- 3M), and its action on the c-AMP content
of slices treated with these two doses of dopamine was
variable.

Apomorphine added alone to the slice system

did not change either renin release rate or tissue c-AMP
content.
These data indicate that:

1) dopamine exerts a

direct stimulatory effect on renin release which may be
mediated by a dopmaine-sensitive receptor mechanism
utilizing c-AMP as the intracellular

mediator~

2) in the

sodium-deficient state and perhaps under sodium-replete
conditions, dopamine may participate in the regulation
of basal renin secretion through changes in intracellular
c-AMP

levels~

and, 3) apomorphine at certain concentrations

may have both dopamine-receptor agonistic and antagonistic
properties.
X

CHAPTER I
INTRODUCTION
Our knowledge concerning the various mechanisms
which control renin secretion from the juxtaglomerular
cells of the kidney has increased at an accelerated pace
during the last ten years.

Davis (1) has classified these

various factors or mechanisms into three major catagories,
1) the intrarenal receptors, which refer to the renal
vascular barorecptors in the renal afferent arteriole
sensitive to stretch due to changes in perfusing pressure
(2-6), and the natrioreceptors of the macula densa in the
distal convoluted tubule sensitive to changes in flux of
sodium (7-13) or chloride

(14-16)~

2) the humoral factors,

which include angiotensin II, vasopressin (17, 18), and
several other factors such as the circulating
catecholamines, sodium, potassium, calcium ions, and the
steriod hormones

(1)~

and 3) the neural factors which appear

to exert their regulatory control over renin secretion
by a direct effect on the juxtaglomerular cells via
norepinephrine or its precursors released from
postganglionic sympathetic nerve terminals in the kidney
(19).

Renin release, in most situations, occurs as a result

of a complex interaction and interplay of these basic
1
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mechanisms rather than by a preferential activity of any
these individually.
It is now clear that the classic intrarenal
mechanisms (i.e. afferent arteriole barorecptors and macula
densa natrioreceptors) play a substantial role in the
control of renin secretion, and that the various other
humoral and hemodynamic factors are also intimately
involved.

In recent years, however, evidence has

accumulated pointing to the sympathetic nervous system
as a very important regulator of renin release, through
effects which appear to be directly exerted on the
juxtaglomerular cells by catecholamines released from
sympathetic nerve terminals.

It is interesting to speculate

that this sympathetic control may turn out to be an
effective tool for fine regulation of renin secretion
according to homeostatic needs, and possibly also the
underlying cause of various pathophysiological alterations
found in a number of hypertensive conditions.
In addition to norepinephrine, a catecholamine
released from renal sympathetic nerve endings, the
possibility of a direct action of norepinephrine precursors
such as dopamine on renin secretion has been examined by
several investigators.

In vivo studies by Anton and Sayer

(20) in 1964, have shown that the kidney contains large
quantities of dopamine,,although the intrarenal location
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is not clear.

Other in vivo studies (21-23} have presented

evidence in favor of the existence of specific renal
dopaminergic receptors, stimulation of which induces
vascular vasodilation.

Additional in vivo (23, 24} and·

in vitro studies (25) have suggested that these dopaminergic
receptors may regulate renin release in addition to
modulating vascular hemodynamics.

Further evidence in

this regard has come from in vitro studies by Henry et
al (26}, which suggest that dopamine-sensitive receptors
are present in renal tissue but these receptors are probably
not dopamine specific.

Thus, further experimentation of

a possible role of dopamine in the regulation of renin
secretion is clearly in order.
of the present study is:

Therefore, the purpose

1} to evaluate, using an in vitro

renal cortical slice preparation, a possible direct
stimulatory effect of dopamine on the renin-secreting
juxtaglomerular cells of the kidney, when added either
alone or in conjunction with specific dopamine receptor
stimulating (apomorphine) or blocking (pimozide} agents;
2) to examine the possibility of a partial dopaminergic
control of basal renin secretion, by the addition of
dopamine-receptor agonistic and antagonistic agents to
nontreated control samples; 3) to elucidate a possible
involvement of cyclic-AMP as an intracellular mediator
of the renin secretory responses to added dopamine and
other agents; and 4) to evaluate the effect of sodium
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deficiency as a potentiating agent of the renin release
responses to natural catecholamine precursors, as suggested
for endogenous catecholamines (norepinephrine).

This

research is important in terms of defining a possible
contributory role of catecholamine precursors (dopamine)
released from renal nerve terminals on the minute-to-minute
control of renin secretion, and would provide additional
evidence toward characterizing the type of adrenergic
receptor partly mediating the renin secretory responses
to sympathetic stimuli.

CHAPTER II
REVIEW OF LITERATURE
To better understand the factors that affect renin
secretion, the role of renin as a vital component of the
renin-angiotensin system must first be reviewed.

This

system, plays a major role in blood pressure control by
regulating plasma angiotensin II, as well as aldosterone
synthesis and release.
A.

The Renin-Angiotensin-Aldosterone System
Renin, a glycoprotein (27, 28), is secreted into

the systemic circulation from the juxtaglomerular cells
of the afferent arteriole of the kidney by various
mechanisms (1, 19, 29, 30).

The juxtaglomerular cells

form part of a larger juxtaglomerular apparatus, which
also includes the macula densa cells of the distal tubules
(1).

It is the juxtaglomerular cells of this

juxtaglomerular apparatus that are responsbile for the
synthesis and release of renin into the afferent arteriole
of the glomerulus (1, 29).

The juxtaglomerular cells are

modified vascular smooth muscle cells (31) that have evolved
into endocrine cells.

Once renin is released, it

enzymatically cleaves four amino acids from the carboxyl
5
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end of angiotensinogen, a tetradecapeptide plasma alpha
globulin, which is produced in the liver.

The resulting

decapeptide, angiotensin I, is further hydrolyzed to an
octopeptide, angiotensin II by a "converting enzyme" (32,
33) which is present in high concentrations in the pulmonary
circulation.

Angiotensin II is considered to be the most

potent vasopressor substance in the body (34), and thus
plays a major role in blood pressure regulation.

Davis

(1), and Laragh (32) also suggest that angiotensin II is
the major stimulus for the synthesis and secretion of
aldosterone by the adrenal glornerulosa cells.

Vaughan

et al (35}, however, have recently indicated that the
primary stimulus for aldosterone biosynthesis is angiotensin
III, a heptapeptide which is formed by the action of plasma
and tissue aminopeptidases on the octopeptide angiotensin
II and perhaps also by hydrolysis of the carboxy-terminal
end tripeptide of angiotensin I.

In turn, aldosterone

plays a vital role in the regulation of extracellular fluid
homeostasis.
B.

Factors Regulating Renin Secretion
As previously indicated, the major interacting

factors involved in the regulation of renin secretion are
classified as follows (1}:

1) intrarenal receptors, which

include the baroreceptors of the afferent arteriole and
the natrioreceptors of the macula densa in the distal

7
tubule; 2} humoral factors, which include locally generated
angiotensin II, vasopressin, circulating catecholamines,
a number of plasma ions and estrogen, among other steroids;
and, 3} neural factors, which primarily include
norepinephrine secreted from renal sympathetic nerve endings
in close association with the juxtaglomerular cells, and
perhaps catecholamine precursors such as dopamine as well.
Renal parasympathetic nerve endings appear to play no role
in the regulation of renin secretion at this time (1}.
1.

Intrarenal Receptors

a}

The Afferent Arteriole Baroreceptor
Evidence for the presence of a renal vascular

receptor partially controlling renin release has existed
for a number of years.

Early studies by Kohlsteadt and

Page (2} on the isolated kidney showed that a decrease
in blood pressure stimulated renin secretion.

It was not

until 1958, however, that studies by Kolff (3} clearly
pointed out that renin or a renin-like substance was
released in response to renal afferent arteriolar
constriction, independent of pulsatile flow.

These

evidence, added together with his own investigations,
allowed Tobian (5} to propose the baroreceptor hypothesis
which postulates that a decreased stretch of the renal
afferent arteriole as a result of decreased blood pressure
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or blood volume, is sensed by specialized baroreceptor
cells on the walls of the afferent arteriole near the
glomerulus, resulting in an increase in renin secretion,
which will eventually lead to generation of angiotensin
II and restoration of blood pressure.
b)

The

Macu~a

Densa Natrioreceptor

In 1945 a funtional relationship between the macula
densa cells and-the juxtaglomerular cells was suggested
by Goormachtigh (7).

Macula densa cells are modified

epithelial cells of the distal convoluted tubules of the
kidney, which appear sensitive to sodium and/or chloride
changes (7-16).

In 1964, Vander and Miller (8) provided

the first experimental evidence that the macula densa is
an intrarenal sensor.

They suggested that a decreased

sodium load or concentration is sensed by the macula densa
cells which then convey this message to the juxtaglomerular
cells to stimulate renin release.

Nash et al (9), have

provided additional evidence for an intrarenal sodiumsensitive mechanism in the regulation of renin secretion.
They suggested that the signal for renin release is mediated
by an altered sodium flux across the macula densa cells.
However, studies by Burg and Green (14), and Kokko (15),
have indicated that the macula densa cells respond to a
chloride load signal, either along with a sodium signal
or preferentially to a sodium signal.

9

2.

Humoral Factors
Among the various humoral factors involved in the

partial regulation of renin release, angiotensin II and
vasopressin (ADH) are the most important.

However, the

mechanisms mediating the effects of these two agents on
renin release are not clear and, moreover, they do not
appear to play as important a role in regulating renin
secretion as the intrarenal receptors and neural factors.
~vivo

studies by Shade (18), have shown that intrarenal

infusion of ADH and angiotensin II inhibit renin secretion.
Furthermore Bunag et al (36), and Ganong and Lopez (30),
have confirmed these findings in regard to a possible local
inhibitory effect of angiotensin II on renin secretion.
Shade et al (18), have further suggested that angiotensin
II may exert its inhibitory effect directly on the
juxtaglomerular cells by a short loop feed-back system
rather than by an indirect action.

This proposed short

loop feedback system mediating the action of angiotensin
II on renin release is consistant with evidence provided
by the in vivo studies of De Champlain et al (37) in man,
Vander et al (17) in dogs, and Blair-West et al (38) in
sheep.

Recent studies by Ganong and Lopez (30), have

additionally suggested that the inhibitory effect of
angiotensin II on renin secretion may be mediated by a
decrease in intracellularly generated cyclic 3' 5' adenosine
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monophosphate, which is consistent with a direct action
of angiotensin II on the juxtaglomerular cells's membranes.
3.

The Renal Sympathetic Nerves and Catecholamines

a)

Juxtaglomerular Apparatus Innervation
The early studies of De Muylder (39), first

described a rich nervous system innervation of the renal
afferent arterioles in the region of the juxtaglomerular
cells.

This initial study was followed by a number of

light and electronmicroscopic studies (31, 40, 41) which
confirmed the early observations, and showed the presence
of numerous nonmyelinated nerve fibers in close association
with the renal afferent and efferent arterioles.

Subsequent

electronrnicroscopic (41) and histochemical fluorometric
studies (42}, have demonstrated the presence of a dense
network of sympathetic nerve terminals in the region of
the renal juxtaglomerular cells.

In addition, the presence

of nerve terminals in close proximity to the macula densa
cells (43) suggests the macula densa is also under neural
modulation~

but, subsequent fluorometric studies (42},

have been unable to confirm this.

Recent studies by Muller

and Barajas {44) have characterized the nerve terminals
innervating the juxtaglomerular cells as being primarily
adrenergic in nature with perhaps some cholinergic
contributions as well.
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b)

Effect of Catecholamines on Renin Release
The morphological evidence regarding the existence

of a dense sympathetic innervation of the juxtaglomerular
cells, triggered the undertaking of numerous in vivo (4548) and in vitro studies (30, 49-51) designed to evaluate
the possibility of a direct sympathetic nervous system
control of renin secretion.

These and related data have

been evaluated in various review papers (1, 19, 29, 52).
These studies have, for the most part, favored the view
that catecholamines, specifically epinephrine and
norepinephrine, stimulate renin release by 1) affecting
the intrarenal receptors (circulating catecholamines from
the adrenal medulla) or 2) by a direct stimulatory effect
exerted on the juxtaglomerular cells themselves by both
circulating catecholamines and those released from renal
sympathetic nerve endings in close association with the
renin-secreting cells.
The mechanisms by which catecholamines stimulate
renin secretion have been extensively studied in vivo by
a number of investigators (37, 45-48, 53).

In one study,

Johnson et al (48) showed that in the nonfiltering kidney,
deprived of macula densa effects, the increase in renin
secretion during intrarenal epinephrine infusion was blocked
by simultaneous intrarenal papaverine administration,
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whereas the response to norepinephrine was sustained during
papaverine infusion.

Since these observations were made

in the nonfiltering kidney with the renal baroreceptor
blocked by papaverine and a nonfunctional macula densa,
Johnson et al {48) suggested that the effect of
norepinephrine was directly exerted on the juxtaglomerular
cells, whereas the failure of epinephrine to act-during
papaverine infusion suggests that the renin release
responses to epinephrine are primarily due to an effect
of this catecholamine on the renal arteriolar baroreceptors.
Studies by Vandongen et al {54, 55) have provided further
evidence suggesting that norepinephrine directly stimulates
renin secretion, and that renin secretion in response to
this catecholamine remains increased even when renal
arteriolar vasoconstriction is blocked with the alphaadrenergic blocker phenoxybenzamine.

The validity of the

data from these in vivo studies, can be questioned because
of the interrelation of the many humoral, hemodynamic and
neural mechanisms regulating renin secretion all of which
may participate in the observed responses.

Thus, in order

to evaluate the possibility of a direct regulatory control
of the sympathetic nervous system on renin release, the
effects of the various humoral and hemodynamic factors
on this release must be effectively eliminated by utilizing
in vitro systems.

Utilizing an in vitro dog cell suspension

system, Mickelakis et al (49) showed that renin secretion
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was increased by both epinephrine and norepinephrine while
Nelly et al (51) using a rat renal cortical slice
preparation have produced data suggesting that the
stimulatory effect of norepinephrine on renin release appear
to be mediated by a beta-adrenergic receptor on the
membranes of the juxtaglomerular cells themselves.

The

possibility of a direct stimulatory effect of catecholamines
on renin secretion has been further supported by numerous
other in vivo (45-48) and in vitro studies (30, 49-51).
In vivo studies by Otsuka et al (45) in the dog,
have shown that the catecholamine-induced renin release
from the juxtaglomerular cells is potentiated under sodiumdeficient conditions, suggesting an enhanced sensitivity
of the renin-secreting cells to adrenergic stimuli in the
sodium-deficient state.

This finding, which has been

supported by others (30, 56) allows an evaluation of
positive and negative effects of sympathetic stimuli on
renin secretion.

Previous evaluations of sub-control renin

secretory responses to sympathetic stimuli were difficult
in view of the already low basal control renin secretion
levels observed in laboratory animals maintained on
commercial chow diets which are rich in sodium.

Thus,

when renin secretory levels become significantly lower
than control levels as a result of the effect of a given
inhibitory agent, the low responses can not be clearly

14

quantitated even by radioimmunoassay.

Commercial rat chow

diets provide approximately 12 times (over 2.2 mEq Na/day)
the amount of sodium recommended by the National Research
Council for growing animals, and thus basal renin secretion
is markedly suppressed.

Conversely, animals maintained

on low sodium diets, receive less than 0.02 mEq of sodium
per day, and they exhibit a much higher basal renin release
levels, which is an ideal starting point in the evaluation
of positive and negative stimulating and inhibitory factors
which affect renin secretion.

More importantly, however,

is the fact that the sodium-deficient animal exhibits a
marked potentiation (hypersensitivity) of its renin
secretory responses to sympathetic stimuli, thus making
renal sodium-deficient in vitro system an ideal tool for
evaluation of sympathetic stimuli on renin secretion.
Utilizing a hypersensitive in vitro renal cortical
slice preparation from sodium-deficient rats, Ganong and
Lopez (30) have examined further some of the mechanisms
by which a variety of sympathetic agents may directly
regulate renin secretion.

Their data are consistent with

those of Ostuka et al (45) in regard to the potentiation
of the renin secretory responses to added catecholamines
in the sodium-deficient animal, and they additionally
indicate that sodium deficiency enhances the sensitivity
of the juxtaglomerular cells to sympathetic stimuli.
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Furthermore, their data (30) suggest that renin secretion
is mediated by a beta-adrenergic receptor (45-47, 50)
mechanism mediated by the generation of intracellular cyclic
AMP, a view that is shared by a number of other
investigators (30, 50, 51, 57).

These data (30) clearly

show that norepinephrine, in addition to its stimulatory
effect on renin secretion when added to kidney slices in
physiological or subphysiological concentrations, also
exerts an inhibitory effect on renin secretion when added
in large concentrations.

This inhibitory effect of large

norepinephrine concentrations on renin secretion, appears
to be mediated by an alpha-adrenergic receptor mechanism
since the alpha-adrenergic blocking agent phentolamine
reversed the inhibition.

Also, this alpha-inhibitory effect

appears to be correlated to a significant decrease in cAMP generation (30).

Additional support for this concept

has come from the recent in vivo studies of Pettinger (58)
and the in vitro studies of Capponi and Volloton (59).
c)

Effects of Dopamine on Renin Secretion
Dopamine is an obligatory precursor in the

biosynthesis of catecholamines in the brain (60), adrenal
medulla (61), and sympathetic nerve terminals (62).

The

possibility of a direct action of this catecholamine
precursor on renin secretion has been examined with
inconclusive results, primarily because most of the studies
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were done in vivo and other factors could likely have
contributed to the observed responses.

Thus, in vitro

renal preparations, which effectively remove humoral,
hemodynamic, and other in vivo influences, clearly need
to be used as the best alternative tools.

The in vivo

studies of Anton and Sayer (20) have shown that the kidney
contains large quantities of dopamine, although the source
whether circulating and/or nerve terminal-secreted is not
clear.

Data from various in vivo (23, 24, 63-65) and in

vitro (26) investigations have suggested that dopamine
stimulates renin release, but the mechanisms involved in
this release are not clearly defined.

Other in vivo studies

(66) have suggested that dopamine stimulates renin release
indirectly by stimulating the intrarenal baroreceptors,
rather than by a direct effect on the juxtaglomerular cells.
Conversely, Ayers et al (65) found that dopamine infusion
instead of causing a decrease in renin secretion which
one may expect as a result of renal arteriolar vasodilation
actually caused the opposite effect.

Goldberg (21) and

Toda and Goldberg (22) have suggested the existence of
renal dopaminergic receptors, stimulation of which induces
renal v'asodilation, but they did not attempt to correlate
these observations with changes in release rates of renin.
Further support for the existence of renal dopaminergic
receptors has come from the in vivo studies of Imbs et
al (23), in which renal perfusion with haloperidol (specific
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dopamine-receptor blocker) rather than with propranolol
(specific beta-adrenergic blocker) suppressed the renin
hypersecretion induced by dopamine.

Recent in vitro studies

by Nakajima et al (25) have shown that dopamine
significantly increased the concentration of c-AMP in a
rat kidney particulate preparation which consisted of
tubules, glomeruli, and blood vessels.

In their work,

addition of either the alpha-adrenergic blocker,
phentolamine, or the beta-adrenergic blocker, propranolol,
failed to significantly reduce the effect of dopamine on
c-AMP concentration.

Conversely the stimulatory effect

of dopamine on c-AMP was selectively blocked by
spiroperidol, a dopamine receptor antagonist.

In addition,

Imbs et al (23, 24} and Nakajima et al (25, 67} have data
further supporting the existence of renal dopaminergic
receptors which appear to differ from renal beta-adrenergic
receptors, and which behave in a manner similar to that
of the intrarenal receptors, thereby indirectly regulating
renin secretion.

In contrast, in vitro studies by Henry

et al (26) suggest that dopamine-sensitive receptors may
be located on the membranes of the juxtaglomerular cells
themselves, but these receptors may not be specific for
dopamine alone but rather of the beta-type, capable of
binding norepinephrine and the other catecholamines as
well.
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In view of the importance of dopamine as a central
neurotransmitter, and the fact that the kidney appears
to contain large amounts of this catecholamine precursor,
further studies are clearly in order to examine a possible
regulatory role of this compound on renin secretion.

Thus,

a series of studies were designed to evaluate such a role,
by examining a possible direct effect of dopamine on renin
release, as well as the possibility that c-AMP may be
involved as a mediator in this process.

In addition the

effects of specific dopamine-receptor agonistic and
antagonistic agents are used to further characterize the
type of receptors mediating the renin secretory responses
to dopamine.

CHAPTER III
MATERIALS AND METHODS
Twenty-four male, Sprague-Dawley rats (Sprague
Dawley Co. Madison, Wisconsin) with initial weights of
210

~

10 grams were fed a sodium-deficient diet (Teklad

Test Diets, Madison, Wisconsin) which provided less than
0.02 milliequivalents of sodium per day, for periods of
time of 2-3 weeks.

The rats were kept two animals per

cage, in a temperature-controlled room (23

~

2°C), with

a 12 hr light/12 hr dark photoperiod, and had access to
distilled, deionized water ad libitum.

After 2-3 weeks

on this diet the animals were sacrificed by decapitation
and their kidneys were rapidly excised, decapsulated, and
gassed with a mixture of 95% oxygen-5% carbon dioxide for
30 seconds, while being maintained in Robinson's buffer
medium at 4°C (68).

Slices of renal cortex approximately

0.3 millimeters thick and weighing 50

~

20 milligrams were

subsequently prepared using a Stadie-Riggs microtome (A.
Thomas, Co.).

Each cortical slice was divided into six

similar portions which were randomly assigned to six
separate incubating vessels containing 2.5 ml of Robinson's
buffer.

The procedure was repeated using slices from other

areas of the renal cortex until each vessel contained 50
19

20
~

20 milligrams of renal cortical tissue.

This tissue

distribution insured a homogeneous population of renal
cortical cells in each incubating vessel.

The slices were

then pre-incubated for 15 minutes at 37°C in a shaking
Dubnoff Metabolic Incubator (Precision Scientific Co.),
in an atmosphere saturated with 95% oxygen-5% carbon
dioxide.

The pre-incubated slices were subsequently

transferred to similarly numbered vessels containing fresh
Robinson's buffer maintained at 37°C and were then incubated
for one hour under conditions identical to those during
pre-incubation.

One of each group of six vessels served

as a nontreated control, while the other five vessels
received respectively, one of various dopamine doses (Sigma
Chemical Co.) ranging from lo-9 Molar to lo-3 Molar, which
were added either alone or in conjunction with the dopaminereceptor agonist agent apomorphine (10-6M) or the dopaminereceptor blocking agent pimozide (1o-6M).

Apomorphine

(1o-6M) and pimozide (1o-6M) were also added alone to the
remaining vessels.

Both agonistic and antagonistic agents

were added to the slice preparation before the preincubation as well as incubation periods, whereas dopamine
was only added at the begining of the incubation period.
Dopamine and apomorphine solutions were prepared in 0.1%
ascorbic acid (Sigma Chemical Co.) to prevent oxidation
of the catecholamine and the dopamine-receptor agonist.
(Free, Lopez, Ganong, unpublished observations).

Pimozide
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was prepared in 0.1% tartaric acid (Janssen Pharaceutica)
which also prevented oxidation of the dopamine-receptor
antagonist agent.

After incubation, the incubated

supernatant medium was collected in 12 X 75 mm tubes
(Scientific Products) and stored at -20°C until assayed
for renin concentration by radioimmunoassay (RIA) of
angiotensin I (Squibb).

The slices were rapidly frozen

on dry ice and subsequently homogenated in 1 ml of 8%
trichloroacetic acid (TCA).

Homogenates were then

transfered to 12 X 75 mm tubes containing 5 drops of 0.1
N HCl, vortexed, and immediately centrifuged at 4000 rpm
for 10 min at 4°C.

The protein-containing precipitate

was discarded and the supernatant was trasfered to conical
centrifuge tubes using Pasteur pipets.

The samples were

then washed 4 times with water-saturated ether
(Mallinckrodt), vortexed for 10 sec each time, and the
upper, ether-containing phase, aspirated using Pasteur
pipets and discarded after each wash.

In turn, the lower,

c-AMP-containing water phase, was decanted after each wash
into appropriate glass vials which had been set on dry
ice for immediate freezing.

The frozen vials containing

the water-soluble c-AMP were subsequently lyophyllized
(Virtix lyophyllizer) for 4-5 hours to remove the water.
The freeze-dried cyclic AMP was then stored at -20°C until
assayed by a modification of the competitive protein binding
assay of Gilman (69).
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A.

Renin Concentration Determination of Radioimmunoassay

of Angiotensin I
1. Angiotensin I Generation
Since purified renin is not available, there is
no direct radioimmunoassay of renin.

In order to determine

renin concentration, a method has been developed for the
estimation of renin concentration through the
radioimmunoassay of angiotensin I generated by the action
of renin on incubated supernatant samples in the presence
of renin substrate (angiotensinogen).

To generate

angiotensin I, the frozen incubated supernatant samples
which had been kept at -20°C were allowed to thaw at room
temperature and subsequently maintained at 4°C in an icewater bath.

Defrosted supernatant samples were vortexed

for 15 seconds and 0.025 ml aliquots of each unknown were
transfered to labeled 12 X 75 mm pyrex tubes also kept
at 4°C.

To each tube, l ml of 24-hr nephrectomized dog

plasma, which has been dialyzed against phosophate-EDTA
buffer was added.

Prior to its addition to the incubated

supernatant samples, the 1 ml nephrectomized dog plasma
aliquots containing endogenous renin substrate
(angiotensinogen) were treated with 0.05 ml of a 1% solution
of

phen~lmethysulfonealfluride

(Sigma Chemical Co.) an

inhibitor of plasma converting enzyme and other plasma
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angiotensinases, to prevent degradation of generated
angiotensin I or conversion of angiotensin I to angiotensin
II.

The inhibitor-treated nephrectomized dog plasma

aliquots were then adjusted to a pH of 5.4 - 5.7 with 1%
HCl to insure an optimium renin enzymatic activity.

The

unknown supernatant samples tq which the nephrectomized
plasma substrate had been added, were then incubated in
a water bath at 37°C for two hours to allow generation
of angiotensin I.

Following this 2-hr generation period,

the samples were removed from the water bath and 1 ml of
distilled, deionized water was added.

The angiontensin

I containing samples were then vortexed, covered with
aluminum foil to prevent evaporation, and immersed in
boiling water for 2-3 minutes, to stop any further reaction
by precipitation of most proteins except angiotensin I
which is heat stable.

At the end of the boiling period,

the angiotensin I containing samples were allowed to cool,
covered with parafilm (Fischer Co.), and stored at -20°C
until assayed for angiotensin I content by radioimmunoassay.
2.

Radioimmunoassay Procedure of Angiotensin I
Renin concentration was determined by RIA of

angiotensin I utilizing materials purchased from the Squibb
Co. (Rolling Meadows).

This procedure used a specific

antibody for angiotensin I 125Iodine-labeled angiotensin
I as the radioactive tracer and synthetic angiotensin I
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as a reference standard.

Duplicate unknown sample aliquots

used for the RIA procedure were either 0.025 ml, 0.05 ml
or 0.1 ml depending on the concentration of angiotensin
I present in the samples.

Following charcoal separation,

the samples were centrifuged at 4500 rpm for 10 min at
4°C using a sorvall RC2-B refrigerated centrifuge and the
supernatant decanted into 12 X 75 mm tubes for counting.
Counting time was 1 minute.

The various steps in this

RIA procedure have been outlined in detail (Squibb).
B.

Determination of Cyclic 3' 5' Adenosine Monophosphate

(c-AMP) By Competitive Protein Binding Assay
Freeze-dried c-AMP samples obtained after
lyophylization, were reconstituted with 0.25 ml of 4 mM
Tris/EDTA buffer pH 7.5 (Amersham).

Duplicate 0.05 ml

aliquots of the reconstituted unknown samples were mixed
in 12 X 75 mm tubes with 0.10 ml of binding-protein, and
0.05 ml of 3H-labeled c-AMP, to a total assay volume of
0.2 ml.

C-AMP standards were prepared similarly.

The

samples were vortexed for 15 seconds and then allowed to
incubate at 4°C for 90 minutes.

At that time, 0.2 ml of

a charcoal suspension (Amersham) were added to the coldincubated samples to separate protein-bound from free cAMP, the samples were vortexed for 5 seconds and immediately
centrifuged at 4°C for 10 minutes at 3500 rpm.

0.2 ml

of the supernatant were subsequently counted in a tri-carb
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liquid sintillation spectrophotometer.
C.

Statistical Calculations
Statistical significance of the c-AMP content and

renin secretion was evaluated by a modified paired student's
"t" test (70} using a programable desk top calculator
(Hewlett-Packard, 1900B}.

CHAPTER IV
RESULTS
In an initial study, the effect of dietary sodium
changes on basal renin release and cyclic-AMP content of
rat renal cortical slices was evaluated.
be seen in figure 1.

These data can

As observed in this figure, the basal,

non-stimulated, renin release rate in slices from sodiumdeficient rats was significantly greater (P < 0.01) when
compared to that seen in the sodium-replete animals.

In

turn, the cyclic-AMP content of slices from sodium-deficient
rats was not significantly different from that of slices
from the sodium-replete group of animals (figure 1).
Based upon the data obtained from the preliminary
study, a renal cortical slice system prepared from sodiumdeficient rats was utilized in all subsequent studies.
Figure 2 depicts the changes in renin release in slices
from sodium-deficient rats in response to various
concentrations (10-9M, 10-7M, 10-sM, and 1o-3M) of dopamine
hydrochloride.

As shown in this figure, dopamine doses

of 10-9M and 10- 7M were ineffective in stimulating renin
secretion.

Conversely, higher concentrations of this

catecholamine (10-SM and 10-3M), significantly stimulated
26
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renin release, with the highest mean renin release values
seen at a dopamine concentration of 10-sM.

However, a

statistical comparison between the two stimulatory
concentrations of dopamine showed no significant differences
between them with respect to stimulation of renin secretion.
When their stimulatory effects on renin release were
compared to those exerted by lower dopamine doses (1o-9M
and 1o-7M) a dose-response relationship was clear.

Thus,

these data (figure 2) indicate that threshold for maximal
stimulation of renin release was reached with a dopamine
concentration of 10-SM, and that higher doses of this
catecholamine were ineffective in further potentiating
the renin secretory rate.
When the renin secretory responses to various
dopamine doses (figure 2) are compared to those in c-AMP
content in response to the same dopamine concentrations
(figure 3) a partial correlation can be observed.

These

data (figure 3) show that at a concentration of 1o-3M,
dopamine significantly stimulated both renin release and
c-AMP content in cortical slices from sodium-deficient
rats.

At 10-sM, however, dopamine significantly stimulated

renin release, but did not affect c-AMP content.

Dopamine

concentrations of 10-7M and 10-9M did not change c-AMP
content from that of controls, which is consistent with
the changes seen in renin secretion in response to the

FIGURE 3
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same doses of this catecholamine (figure 3).

As seen with

the renin secretory responses to the four dopamine
concentrations, a dose-response relationship is also
apparent in regard to the c-AMP content changes (figure
3)•

Data from a subsequent study designed to evaluate
the possibility of a specific dopaminergic-receptor
mechanism mediating the renin release and c-AMP content
responses to added dopamine are shown in figure 4.

This

figure illustrates the renin secretory changes seen in
renal cortical slices from sodium-deficient rats in response
to four dopamine doses (1o-9M, 1o-7M, 1o-5M and 1o-3M),
added either alone or in conjunction with a dopaminereceptor blocking agent, pimozide (1o-6M).

As observed

(figure 4), when added together with two dopamine doses
(1o-9M and 1o-7M), which by themselves were ineffective
in stimulating renin release, pimozide did not affect the
renin release responses observed with dopamine alone
although it did depress the mean renin release rates.
Conversely, when added in conjunction with higher dopamine
doses (10- 5M and 10- 3M) pimozide effectively prevented
the significant stimulatory effect of these dopamine
concentration on renin release.

Furthermore, addition

of pimozide alone to the renal cortical slice preparation
significantly decreased renin secretion in relation to

FIGURE 4
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the non-stimulated control samples.
When the renin release data on figure 4 are compared
to those in c-AMP content in response to the same four
doses of dopamine plus pimozide (figure 5), a clear
correlation between renin release and c-AMP content changes
can be observed.

The inhibitory effect of pimozide was

particularly striking in regard to cyclic-AMP content since
it not only prevented the significant stimulatory effect
of 10-3M dopamine on c-AMP content but it significantly
decreased the c-AMP content levels of tissue slices treated
with all four dopamine doses to values far below those
of non-treated control slices.

Pimozide added alone

significantly decreased both renin release as well as the
c-AMP content of the tissue slices in relation to the nonstimulated control samples.
Table 1 illustrates the results of an additional
study designed to evaluate the effect of the dopaminergic
receptor agonist apomorphine (10-6M), on the renin release
and c-AMP content responses to four dopamine doses (1o-9M,
10-7M, 10- 5 M and 10-3M) in renal cortical slices from sodiumdeficient rats.

As opposed to pimozide, when added alone

the slice preparation, apomorphine did not alter renin
secretion or c-AMP content levels in relation to those
of controls.

However, it did prevent the stimulatory effect

of 10-SM and 10-3M dopamine concentrations on renin release

I
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when added in conjunction with the catecholamine.
Furthermore, apomorphine prevented the significant
stimulatory effect of 10-3M dopamine on c-AMP content
although when compared to each other (1o-3M dopamine alone
vs. 1o-3M dopamine plus apomorphine) there was no
significant difference in the effect of both treatments
on c-AMP content.

Apomorphine did, however, potentiate

the c-AMP content responses of renal cortical slices to
10- 5M dopamine, but again, comparison of the two values
(10-SM dopamine alone vs. 10-SM dopamine plus apomorphine)
showed no significant statistical differences.

From these

data (table 1) it is clear that at no time apomorphine
potentiated the effects of any of the stimulatory dopamine
doses on renin release and in fact it prevented the
stimulation seen with 1o-5M and 10-3M dopamine doses added
alone to the slice preparation.

CHAPTER V
DISCUSSION
Studies utilizing in vitro kidney preparations
(30, 49-51, 71} have provided evidence supporting the
concept of a direct stimulatory effect of catecholamines
on the juxtaglomerular cells of the kidney to affect renin
release.

In these preparations, the influence of various

humoral, hemodynamic, and other factors which are known
to influence renin release in the intact animal are
eliminated, and although the various cell types are still
present in the in vitro preparations, the effects of added
catecholamines on renin release are most likely due to
a direct effect on the renin-secreting cells.

Furthermore,

there is in vivo (45, 56) and in vitro (30, 72) evidence
which indicates that sodium deficiency not only potentiates
the renin secretory responses to sympathetic stimuli; but
that it causes a chronic hypersecretion of renin resulting
in elevated basal renin release levels (30, 72}.
Thus, in an initial study utilizing as in vitro
rat renal cortical slice preparation we evaluated the effect
of dietary sodium changes on renin release and c-AMP content
of kidney slices from animals which had been fed either
42
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sodium-deficient or sodium-replete diets for 2-3 weeks.
The results from this initial study (figure 1) confirmed
previous findings (30, 72) indicating that the basal, nonstimulated renin release rate in renal cortical slices
from sodium-deficient rats is significantly greater than
that seen in slices from sodium-replete animals.
Surprisingly, however, c-AMP content levels in slices from
both sodium-deficient and sodium-replete rats were not
different statistically, suggesting that the increased
renin release rate seen in sodium-deficient animals may
not involve changes in the intracellular concentration
of this nucleotide.

There are no previous data in this

regard to allow for a comparison of our results on c-AMP
content changes in response to dietary sodium manipulation.
In a subsequent study (figures 2 and 3) the effect
of various concentrations of dopamine hydrochloride on
renin release and c-AMP content in renal cortical slices
from sodium-deficient rats was evaluated.

As shown in

these figures~ two concentrations of dopamine (10-SM and
10-3M) significantly stimulated renin release, with
threshold for a maximal renin secretory rate being observed
at a dopamine concentration of lo-SM.

Conversely, lower

dopamine concentrations (1o-9M and 10-7M) were ineffective
in stimulating renin release.

The results seen with the

stimulatory concentrations of dopamine are consistent with
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previous in vivo (23, 24, 63-65) and in vitro (26)
observations which suggest that renin release may partially
be under dopaminergic control.

However, most of these

studies above have not attempted to postulate a possible
mechanism or mechanisms mediating the stimulatory action
of dopamine or renin secretion.

The in vitro renin release

data (figures 2 and 3), on the other hand, suggest that
the stimulatory effect of dopamine on renin release may
be a direct one on the juxtaglomerular cells, a postulation
which is in agreement with some (26).

In partial support

of this view are the data obtained in these studies (figure
3) in regard to the c-AMP content changes seen in kidney
slices in response to the highesi concentration of added
dopamine (10-3M) examined.

The fact that both renin release

rate and c-AMP content levels were significantly increased
in response to this dopamine dose, clearly supports the
possibility that dopamine may stimulate renin secretion
by interacting with a membrane receptor which utilizes
c-AMP as the intracellular mediator.

Furthermore, even

when the tissue c-AMP content levels were not significantly
elevated in response to other dopamine doses (figure 3),
they nevertheless paralleled at all times the changes seen
in renin secretion in response to the same dopamine
concentrations, further supporting a c-AMP-mediating action.
It has been postulated that stimulation of renin release
by other catecholamines is mediated by an increased
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intracellular c-AMP generation and that dopamine may exert
its action on renin secretion in a similar manner (25}.
The renin release and tissue c-AMP content data (figures
2 and 3} are consistent with this view, but do not clarify
whether the membrane adenylate cyclase receptor complex
activates by dopamine is specific for this catecholamine
or whether it is of the beta-type which is responsive to
all catecholamines as proposed by some investigators (26}.
To further explore the possibility of a dopaminespecific receptor complex mediating the action of this
catecholamine on the juxtaglomerular cells, changes in
renin release and c-AMP content of renal cortical slices
from sodium-deficient rats in response to various dopamine
doses added either alone or in conjunction with a specific
dopamine-receptor blocking agent pimozide (1Q-6M) studied
(figures 4 and 5).

Addition of pimozide to the kidney

slice system not only prevented the significant stimulatory
effect of two dopamine doses (1o-5M and 1o-3M} but it
significantly inhibited the basal renin secretion of the
tissue slices when added alone (figures 4 and 5).
Similarly, pimozide significantly decreased renal cortical
tissue slice c-AMP content when added alone or in
conjunction with all dopamine concentrations utilized
(figure 5}.

Numerous studies (21-25} have proposed the

existence of specific dopaminergic receptors, but other
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(26) have indicated that these dopamine-sensitive receptors
may not be specific for dopamine alone but rather of the
the beta type, capable of binding other catecholamines
as well.

These data (figures 4 and 5) support the concept

that stimulation of renin release by dopamine is mediated
by an increased intracellular c-AMP generation via a
specific dopamine receptor mechanism.

This view is shared

by other investigators (25) but in their studies no attempt
was made to measure renin release and c-AMP content changes
simultaneously.

Thus, the results obtained as a result

of simultaneous evaluation of renin release and c-AMP
content changes in these studies provide strong support
for the existence of a specific dopamine-receptor mechanism
mediating the action of this catecholamine on renin
secretion.

Furthermore, the significant inhibition seen

in renin release and c-AMP content of slices treated with
pimozide alone (figure

5~,

suggests that endogenous dopamine

exerts a partial regulatory control over the basal renin
secretory levels in the intact animal, and that this control
may be mediated by intracellular c-AMP changes.

The

significance of this is not clear, but these observations
certainly indicate that not only norepinephrine released
from renal nerve endings but also dopamine, perhaps from
the same source, may work in conjunction to modulate the
minute-to-minute basal renin secretory rate in vivo.
alternative possibility may be proposed in view of the

An
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fact that the basal renin release rate in the sodiumdeficient animal is significantly greater than that seen
in animals fed commercial chow diets.

It is possible that

the renin hypersecretion seen in sodium-deficient animals
is the one under a partial dopaminergic control and that
the basal renin secretory levels observed in sodium-replete
animals are under a difference type of control.

Obviously,

studies utilizing pimozide in slices from sodium-replete
rats are clearly needed to evaluate this possibility and
they are presently being conducted in our laboratory.
Potentiation of the stimulatory effects of two
dopamine doses (10-SM and 10-3M) on renin secretion, by
the simultaneous addition of a dopmaine-receptor agonist
apomorphine (10-6M), was not observed in these studies
as the concentration of apomorphine utilized (table 1).
In fact, apomorphine actually prevented the stimulatory
effect of dopamine (lo-SM and 1o-3M) on renin release.
Although these results appear contradictory to what one
may expect from the postulated action of apomorphine, they
are nevertheless in agreement with another study (71) which
has suggested that apomorphine at certain concentrations
is antagonistic to dopamine action.

The effect of

apomorphine on tissue c-AMP content in our studies was
not clear.

It did inhibit the increase in c-AMP content

seen in slices treated with 1o-3M dopamine, but it
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significantly stimulated c-AMP content of slices treated
with 10- 5M dopamine.

These observations suggest that,

whether stimulatory or inhibitory, the mechanism action
of apomorphine on dopamine receptors may be independent
of c-AMP changes.

Further studies are clearly needed in

this regard.
In summary, the data discussed in this thesis
confirm previous observations which have been shown that
the basal, non-stimulated renin release rate in renal
cortical slices from sodium-deficient rats is significatnly
greater than that seen in sodium-replete animals.

These

data also indicate that dopamine exerts a direct stimulatory
effect on renin release which appears to be mediated by
a dopamine-sensitive receptor mechanism utilizing c-AMP
as the intracellular mediator.

Furthermore, the effect

of dopamine on renin secretion and c-AMP content of slices
from sodium-deficient rats appears to be concentrations
dependent, ruling out leakage from the cells as a
contributing factor in the results observed.

Additionaly,

these results suggest that dopamine may be an important
endogenous modulator of the basal renin secretion seen
in non-stimulated, sodium-deficient juxtaglomerular cells,
although similar results in slices from sodium-replete
animals are needed to further support this view.

Finally,

these data are inconclusive as to the actual effects exerted
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by apomorphine on renin release and tissue c-AMP content,
and additional doses of this dopamine-receptor agonistic
agent clearly need to be evaluated.
The data presented in this paper constitute
additional evidence supporting the concept that the
sympathetic nervous system exerts a direct regulatory
control over the secretion of renin from the juxtaglomerular
cells of the mammalian kidney, and support the view that
dopamine-sensitive receptor mechanisms may participate
in this control.
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APPENDIX A
1.

Radioimmunoassay Calculations

To correct for dilution of the initial unknown
sample aliquot (0.025) throughout the generation procedure
and subsequent RIA, as well as to convert the RIA values
expressed as picograms of A-1 to the final values in
nanograms of angiotensin I/mg wet tissue/hr, which is the
conventional way of expressing renin concentration, the
following formula was employed:
Renin
Concentration
= pg of A-I X 40 X 2 X (40, 20, or 10) X 2.5
expressed as
2 X loa
ng A-I/rng wet tissue/hr
mg wet tissue
In numerator:
pg of A-I

=

picograms of angiotensin I determined
for unknown samples by reading off
the RIA standard curve for angiotensin I

40

=

a factor obtained by diluting the
initial 0.025 ml of incubated
supernatant with 1 ml of 24-hr
nephrectomized dog plasma plus
inhibitor

2

=

a factor obtained by diluting 1 ml
of generated sample with 1 ml of
distilled, deionized water following
a 2-hr generation of angiotensin I

40, 20, or 10

=

a factor which depends on the
unknown generated sample aliquot
size (0.025 ml, 0.05 ml, 0.1 ml}
used for the RIA procedure,
when diluted to a final assay
volume of 1 ml
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=

a factor which represents the original
volume of Robinson's buffer that was
used to incubate the renal cortical
tissue.

2

=

a factor which converts the 2-hr
generation time of angiotensin
I to 1 hr.

1000

=

a factor which converts picograms
of angiotensin I to nanograms
angiotensin I.

mg

=

milligrams of wet renal tissue weight.
This factor converts nanograms
angiotensin I per hour to nanograms
angiotensin I per hour Per milligrams
wet renal tissue weight.

2.5

In denominator:

2.

Cyclic AMP Calculations

Since only 0.050 ml aliquots of the total 0.25
ml volume of tris/EDTA reconstituted unknown samples was
utilized for the CPB assay, the value for the unknown,
expressed as picograms of c-AMP were corrected for this
by a 5.0 multiplication factor.

Additionally, the final

results were corrected for the wet tissue weight of the
samples and expressed as picograms c-AMP per mg wet tissue.

'
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